相关实验视频

Updated: May 9, 2025

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

血造干细胞移植对高风险AML的结果:儿童瘤学小组的报告

Benjamin J Huang^1,2, Lauren K Meyer³, Todd A Alonzo⁴

¹Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

|April 28, 2025

概括

造血干细胞移植 (HSCT) 改善了患有高风险急性髓性白血病 (AML) 的儿科患者的治疗结果. 这项研究证实了HSCT对当代高风险因素患者的益处,显示了无病生存率的改善.

科学领域:

儿科血液学瘤学儿科血液学
干细胞移植干细胞移植
急性髓性白血病研究研究

背景情况:

儿童高风险急性髓性白血病 (AML) 需要有效的巩固疗法.
高风险AML的定义随着新的预后因素而演变.
造血干细胞移植 (HSCT) 是一种潜在的巩固策略.

研究的目的:

评估HSCT是否改善了当代高风险AML的儿科患者的治疗结果.
为了比较HSCT与第一次完全缓解的单独化疗 (CR1).

主要方法:

来自COG第三阶段试验AAML0531和AAML1031的综合数据.
根据可测量的残留疾病 (MRD) 和高风险的细胞遗传/分子 (CM) 变化重新分类的患者.
在CR1中对HSCT的结果 (复发,DFS) 与CR1中单独化疗的结果 (复发,DFS) 的比较.

主要成果:

在高风险的CM和具有MRD阳性的标准风险 (SR) CM中,HSCT减少了复发和改善了DFS.
在高风险的CM患者中,5年DFS从化疗的26.0%增加到HSCT的49.8% (P<.001).
在SR CM/MRD+患者中,DFS在HSCT下从16.9%提高到50.9% (P = .032).

结论:

造血干细胞移植 (HSCT) 显著改善了患有高风险AML的儿科患者的治疗结果.
HSCT是当代高风险AML的一个有益的整合策略,除了染色体7或5丢失的病例.

更多相关视频

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...